Non-steroidal brassinosteroid mimetic
AssigneesVib Vzw, Universiteit Gent
InventorsDominique Audenaert, Tom Beeckman, Bert De Rybel, Jenny Russinova, Dirk G. Inze
Life of this patent
Estimating the term…
Abstract
The present invention relates to non-steroidal mimetics of brassinosteroids. More specifically, it relates to non-steroidal monocyclic compounds, capable of rescuing the brassinosteroid receptor null mutation bri1-116. Preferably, said compounds are low molecular weight, monocyclic halogenated compound.
Claims3
A method of inducing gene expression, the method comprising:
- applying to a plant a non-steroidal, monocyclic brassinosteroid mimetic, having the formula
- wherein (a) X represents hydrogen or a halogen (b) Y represent carbon or nitrogen (c) Z
- represents hydrogen or a positively charged nitrogen (d) R1 represents hydrogen or a methyl
- group and (e) R2 represents hydrogen, a hydroxyl, methyl or carboxy group.
A method of inducing brassinosteroid depending, BRI1 independent, gene expression, the method comprising applying to a plant a non-steroidal, monocyclic compound selected from a group consisting of
- 4-[(5-fluoro-2-pyridinyl)amino]-4-oxobutanoic acid,
- 4-[(5-chloro-2-pyridinyl)amino]-4-oxobutanoic acid,
- 4-[(5-bromo-2-pyridinyl)amino]-4-oxobutanoic acid, and
- 4-[(5-iodo-2-pyridinyl)amino]-4-oxobutanoic acid,
- to induce said gene expression.
Dependencies are inferred from the claim text.